Intangibles, net (Narrative) (Details) - USD ($) $ in Millions |
3 Months Ended | |
|---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
| Dermira, Inc. a subsidiary of Eli Lilly [Member] | ||
| Finite-Lived Intangible Assets [Line Items] | ||
| Payments of milestones | $ 7.5 | |
| Journey [Member] | ||
| Finite-Lived Intangible Assets [Line Items] | ||
| Payments of milestones | 10.0 | |
| Amortization of intangible assets | $ 1.0 | $ 0.6 |
| Minimum [Member] | Journey [Member] | ||
| Finite-Lived Intangible Assets [Line Items] | ||
| Intangible assets, estimated useful lives | 3 years | |
| Maximum [Member] | Journey [Member] | ||
| Finite-Lived Intangible Assets [Line Items] | ||
| Intangible assets, estimated useful lives | 9 years | |
| X | ||||||||||
- Definition It represents payments of milestone. No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|